ELV Elevance Health, Inc.

bearish track record → $323.05 +7.23 (+2.3%)
Get emailed when ELV changes direction
Mkt Cap $69B P/E 12.4 fwd 10.7 52wk $273.71 - $441.47 Earnings 2026-04-21 2h ago
Insider selling: $36,065,220 sold by 22 insiders (30d)
Est. revisions: +0.9% (2 up, 2 down in 30d)
Factor Model (net +0.2)

Factor Model

net +0.2 1.7 / 10
Est. Revisions
+0.1
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0

Truist cuts ELV target, keeps Buy rating

Watch: Next quarterly earnings for guidance updates on member growth and Medicaid rate impacts amid regulatory scrutiny.

Truist reduced Elevance Health's price target to $375 from $390 while maintaining a Buy rating due to steady demand and stable reimbursement. Evercore ISI started coverage with an In Line rating and $345 target, citing downside risks to 2027 estimates amid policy changes. Insider activity shows heavy selling valued at over $36M, offset partially by $3.7M in insider buys, indicating mixed confidence inside the company.

Despite regulatory and policy risks flagged by Evercore, steady demand and favorable structural tailwinds support a cautiously bullish view on Elevance's healthcare services growth and financial flexibility.

Evidence

5d ago Insider buy by DEVORE SUSAN D (ELV): $374,580
5d ago Insider buy by BOUDREAUX GAIL A KOZIARA (ELV): $2,438,951
5d ago Insider buy by COLLIS STEVEN H (ELV): $869,520
5d ago Insider sell by BOUDREAUX GAIL A KOZIARA (ELV): $17,033,395
5d ago Insider sell by NORWOOD FELICIA F. (ELV): $10,832,155
5d ago Truist Securities main ELV: Buy → Buy
7 older signals
Fundamentals & Data ▾
Elevance Health, Inc. Healthcare · Healthcare Plans
Mkt Cap
$69B
P/E
12.4 fwd 10.7
Beta
0.50
Div Yield
218.00%
52w Range
$273.71 - $441.47
Short Interest
4.0M 2.02%
Days to Cover
1.7 -6%
Technicals downtrend
from 52w Hi
0.0%
1w return
+3.7%
Insiders
selling 0B / 5S
Analysts
mixed
EPS Estimate
$10.77 +0.9% 30d 2up / 2dn
Est. Dispersion
44% 20 analysts
Analyst Target
$378 $317 - $474
Options P/C
0.50
Insider Cluster
strong buy 3B / 8S (officer)
Financials
Revenue
$49.7B +10% YoY
FCF
$-209M
Momentum: decelerating
Recent Filings & Data
insider trade 55
net selling · $36,065,220 sold · $3,683,051 bought
22 insiders · 55 transactions (30d)
Recent transactions
SCHULMAN AMY W. · sell · $7,475
KENDRICK CHARLES MORGAN JR · sell · $910,604
COLLIS STEVEN H · buy · $869,520
HAYTAIAN PETER D · award
PENCZEK RONALD W · award
LAVU RATNAKAR · award
NORWOOD FELICIA F. · award
KAYE MARK · award
KENDRICK CHARLES MORGAN JR · award
CRAIG RYAN R · award
WESSLING ERIN M · award
BOUDREAUX GAIL KOZIARA · award
SCHULMAN AMY W. · award
CRAIG RYAN R · award
WESSLING ERIN M · award
DEVORE SUSAN D · buy · $374,580
COLLIS STEVEN H · award
BOUDREAUX GAIL A KOZIARA · buy · $2,438,951
HAY LEWIS III · award
CLARK RONALD KERRY · award
PERU RAMIRO G · award
NERI ANTONIO F · award
JALLAL BAHIJA · award
STRABLE-SOETHOUT DEANNA D · award
SCHNEIDER RYAN M. · award
DIXON ROBERT L JR · award
DEVORE SUSAN D · award
KAYE MARK · sell · $1,949,074
PENCZEK RONALD W · sell · $183,903
KENDRICK CHARLES MORGAN JR · sell · $1,388,635
HAYTAIAN PETER D · award
PENCZEK RONALD W · award
LAVU RATNAKAR · award
NORWOOD FELICIA F. · award
KAYE MARK · award
BOUDREAUX GAIL A KOZIARA · award
KENDRICK CHARLES MORGAN JR · award
HAYTAIAN PETER D · award
KENDRICK CHARLES MORGAN JR · award
KENDRICK CHARLES MORGAN JR · sell · $3,205,182
PERU RAMIRO G · sell · $400,235
BOUDREAUX GAIL A KOZIARA · sell · $17,033,395
DIXON ROBERT L JR · sell · $154,562
HAY LEWIS III · award
CLARK RONALD KERRY · award
TALLETT ELIZABETH E · award
PERU RAMIRO G · award
NERI ANTONIO F · award
JALLAL BAHIJA · award
STRABLE-SOETHOUT DEANNA D · award
SCHNEIDER RYAN M. · award
DIXON ROBERT L JR · award
DEVORE SUSAN D · award
NORWOOD FELICIA F. · sell · $10,832,155
NORWOOD FELICIA F. · exercise · $1,790,837
15 signals · latest 3h ago

Get alerted when ELV changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.